FDA Inspection 1003848 — Perrigo New York, Inc.

Perrigo New York, Inc. — FEI 2450054

The FDA completed an inspection of Perrigo New York, Inc. on March 8, 2017 in Bronx, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bronx, NY (United States)

Citations

IDCFRDescription
430321 CFR 211.67(b)Written procedures fail to include
434221 CFR 211.142(b)Storage under appropriate conditions